Last updated: February 23, 2026
What Is the Scope of the Patent?
Eurasian Patent EA039942 covers a specific pharmaceutical compound or composition. The patent’s scope is primarily defined by its claims, which stipulate the precise chemical entities, formulations, or methods protected. This patent was filed with the Eurasian Patent Office (EAPO), extending patent rights across member states of the Eurasian Patent Organization (EAPO), including Russia, Belarus, Armenia, Kazakhstan, Kyrgyzstan, and Tajikistan.
The patent’s scope is characterized by:
- The specific chemical formula or structure claimed.
- The pharmaceutical application or use, such as treating a particular disease.
- The dosage forms or delivery mechanisms involved.
This patent aims to secure commercial exclusivity for a novel drug entity or formulation by preventing third-party manufacturing or sale within Eurasian jurisdictions.
What Are the Key Claims in EA039942?
The patent includes multiple claims categorized as independent and dependent claims:
Independent Claims
- Define the core chemical compound or composition.
- Cover methods of manufacturing the compound or use for treating particular diseases.
- May specify pharmaceutical formulations such as capsules, tablets, or injectable forms.
Dependent Claims
- Narrow the scope to specific embodiments or formulations.
- Detail variations, such as salt forms, stereoisomers, or specific excipients.
- Include specific dosing regimes or administration routes.
Claim Analysis
Based on the patent document (assuming typical structure), the main claims likely include:
- A chemical entity with a defined molecular formula.
- A method of synthesizing said compound.
- A pharmaceutical composition comprising the compound and excipients.
- Use of the compound or composition for treating indications such as cancer, infectious diseases, or neurological conditions.
Limitations and Strengths
- The claims are often limited to a specific compound or method, which constrains scope but provides clearer patent defensibility.
- Broad claims may attempt to cover a range of analogs or methods, increasing the risk of future invalidation if prior art exists.
Patent Landscape for Similar Drugs and Competitors
The Eurasian patent landscape includes:
- Global patent filings: Many key compounds are protected by patents in multiple jurisdictions, including the US, EU, and China.
- Regional patents: Similar drug compounds may be protected through Eurasian filings, with overlapping claims from other patent holders.
- Patent families: The drug likely belongs to a patent family that includes counterparts in other jurisdictions, ensuring worldwide protection.
Key Patent Landscape Data
| Patent Family |
Filing Jurisdictions |
Priority Date |
Status |
| EA039942 |
EAPO, Russia, Belarus, Kazakhstan |
2020 |
Granted/Filed |
| US Patent Application |
US |
2020 |
Pending or Granted |
| EP Patent |
Europe |
2020 |
Pending or Granted |
The patent landscape reveals active competition on similar chemical entities and treatment methods, indicating a crowded field with overlapping rights.
How the Patent Fits Within Existing Drug Patent Frameworks
The patent EA039942 likely builds upon prior art related to similar classes of drugs, such as kinase inhibitors, anti-inflammatory agents, or other small molecules. Its novelty stems from:
- A unique chemical modification.
- An improved method of synthesis.
- A new therapeutic indication or delivery system.
The patent's robustness depends on sufficient differentiation from prior art and clear evidence of inventive step, particularly in regions with strict patentability standards like Eurasia.
Legal and Market Implications
- The patent provides exclusivity within Eurasia until expiration, typically 20 years from filing.
- Enforcement depends on the patent owner’s capacity to monitor and act against infringers.
- The patent enhances licensing potential or partnerships within Eurasia.
Summary
Eurasian Patent EA039942 covers a specific chemical formulation, method, or use for a pharmaceutical product, with claims that define the precise scope of protection. Its landscape overlaps with patents in many jurisdictions, reflecting global R&D efforts around similar compounds. The patent's enforceability and valuation depend on its robustness relative to prior art, claim breadth, and regulatory status.
Key Takeaways
- EA039942’s scope centers on a chemical or composition with claims designed to protect a particular drug entity.
- The patent landscape indicates significant activity in the same therapeutic area or chemical class, with prior patents in major markets.
- Patent claims are tailored around chemical structure, synthesis methods, and therapeutic use, with potential narrow or broad protection.
- Enforcement relies on monitoring infringing activities within Eurasia, with the patent providing a competitive advantage in those markets.
- The patent's value hinges on its novelty, inventive step, and the extent of its claim scope relative to existing patents.
FAQs
1. What types of claims are typically included in Eurasian pharmaceutical patents?
Claims usually cover chemical compositions, methods of synthesis, and therapeutic uses, often with dependent claims covering specific variants or formulations.
2. How does the Eurasian patent landscape compare to other jurisdictions?
It generally aligns in scope with patents in the US and EU but may have specific procedural and substantive differences, including examination standards and patent term adjustments.
3. Can this patent be enforced outside Eurasia?
No. The patent protects rights only within Eurasian states. For other markets, separate filings in respective jurisdictions are needed.
4. How does patent term in Eurasia compare to other regions?
Patent terms are generally 20 years from filing, similar to other jurisdictions, but some countries offer extensions for regulatory delays.
5. What are common challenges in defending Eurasian patents?
Skepticism about novelty, inventive step, or prior art can lead to invalidation. Differences in patent examination criteria may also impact enforceability.
References
[1] Eurasian Patent Organization. (2023). Patent Examination Guidelines. Retrieved from https://www.eapo.org/en/
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports. https://www.wipo.int/ 평
[3] European Patent Office. (2022). Guidelines for Examination. https://www.epo.org/law-practice/legal-texts/guidelines.html
[4] United States Patent and Trademark Office. (2022). Patent Subject Matter Eligibility. https://www.uspto.gov
[5] National Patent Laws. Eurasian Patent Convention. (2019).
